The trademark INCELLIPAN was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on October 3, 2010, and received one opposition filed on October 27, 2010 by FELNUTI, S.L. on Likelihood of confusion. the opponent was represented by CLARKE, MODET Y CÍA., S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 27, 2010
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 2, 2010.
The Appeal with reference B R2018/2011-2 was Trade mark application refused according to Rule 94 CTMIR with decision issued on July 31, 2012 by the EUIPO. The Opposition with reference B 001739732 was refused according to Article 8(1)(b) CTMR with decision issued on August 8, 2011 by the EUIPO.